FEATURED SYMPOSIUM PRESENTATION
Choosing CAR T with curative intent
Dr Natasha Kekre
Dr Natasha Kekre of The Ottawa Hospital, Ottawa, Ontario, Canada reviews clinical trial data and real-world evidence for CAR T in 2L DLBCL, highlighting the importance of early referral
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.